| | |

Screening for Mental Illness: The Merger of Eugenics and the Drug Industry

Ethical Human Psychology and Psychiatry Volume 7, Number 2, Summer 2005 pp. 111-124 Screening for Mental Illness: The Merger of Eugenics and the Drug Industry Vera Hassner Sharav, MLS New York, NY The implementation by the President’s New Freedom Commission (NFC) to screen the entire United States population – children…

AHRP Files Court Brief to Protect Children from Harmful Research

October 1, 2001 Text of AHRP Amicus Brief filed with the Maryland Court of Appeals in support of the Court’s ruling against Kennedy Krieger Institute for exposing children to lead poison in an experiment. The Court of Appeals Decision Validates AHRP’s Stand Against Using Children in Harmful Research Experiments. ___________________________________________________…

|

Protecting Human Subjects in Research: Are Current Safeguards Adequate?

Protecting Human Subjects in Research: Are Current Safeguards Adequate? AHRP Testimony submitted to Congressional Committee April 23, 2002 Vera Hassner Sharav, President, and John H. Noble, Jr., Ph.D., steering committee member, The Alliance for Human Research Protection (AHRP), before the Subcommittee on Public Health, Committee on Health, Education, Labor, &…

FDA: Regulatory Protections for Children. Comments by Sharav, Noble, & Fishman for AHRP

FDA: regulatory protections for children. Comments submitted by Vera Hassner Sharav, John H. Noble, Jr., Ph.D and Howard Fishman, MEd, MSW for AHRP August 6, 2001 To: Dr. Bernard Schwetz Acting Commissioner Food and Drug Administration Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville,…

Risk Bearing Children

Risk Bearing Children February 27, 2001 Would you volunteer your child to be a "risk-bearing" subject in drug experiments? When Jonathan Swift published A Modest Proposal in 18th century Ireland, he offered a sure solution to the country’s hunger and economic ills: The poor could sell their year-old children as…

Infomail Archive, 2005

Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability…

Infomail Archive 2004

Infomail 2004 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Dec 31: FDA to review “missing” drug company documents Dec 30: Family of Woman Killed by AIDS Drug Test Sues Doctors, Manufacturer Dec 30: Doctors, Too, Ask: Is This Drug Right? Dec 29: Bill would shield…

FDA Requests Anticonvulsant Suicide Data Analysis – Boston Globe

FDA Requests Anticonvulsant Suicide Data Analysis – Boston Globe Wed, 20 Apr 2005 Thanks to the persistent advocacy efforts of attorney, Andrew Finkelstein, the FDA has finally sent letters to 14 manufacturers of anticonvulsant drugs, such as Pfizer’s Neurontin, to examine the suicide data from these drugs. Finkelstein began his…

Harvard President Laments China Study – Globe

Date: Wed, 15 May 2002 12:57:32 -0400 Subject: Harvard President Laments China Study_Globe ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) A Human Rights Organization www.researchprotection.org Contact: Vera Hassner Sharav FYI Harvard’s genetic experiments in rural China have elicited much criticism. In December 2000, The Washington Post published a highly critical investigative…

Obesity Researcher AdmitsFabricating Data- $3 Mill Fraud in Gov Grants – Boston Globe

Obesity Researcher AdmitsFabricating Data- $3 Mill Fraud in Gov Grants – Boston Globe Fri, 18 Mar 2005 The Boston Globe reports about the worst case of scientific fraud to come to light. Dr. Eric Poehlman, a star among obesity researchers, faces jail time. He overstated the effects of menopause on…

Why We Need Whistleblowers–One-third US Scientists Admit Unethical Research Practices

Why We Need Whistleblowers–One-third US Scientists Admit Unethical Research Practices Sat, 11 Jun 2005 Although the major focus of these AHRP Infomails has been on the deplorable misconduct by the pharmaceutical industry and government health care agencies, whenever we pointed a flashlight at academia and biomedical scientists, we raised the…